The post ENS Technical Analysis Feb 24 appeared on BitcoinEthereumNews.com. ENS is showing a clear bearish trend with lower highs and lower lows recently; if theThe post ENS Technical Analysis Feb 24 appeared on BitcoinEthereumNews.com. ENS is showing a clear bearish trend with lower highs and lower lows recently; if the

ENS Technical Analysis Feb 24

For feedback or concerns regarding this content, please contact us at crypto.news@mexc.com

ENS is showing a clear bearish trend with lower highs and lower lows recently; if the $5.75 swing low support breaks, the bearish structure may deepen, but BOS above $6.24 could signal a bullish reversal.

Market Structure Overview

ENS’s current market structure is characterized by a clear downtrend on 1D and higher timeframes. The price is trading at $5.95, consolidating in the $5.89-$6.31 range with a 2.62% drop in the last 24 hours. The overall structure follows a lower highs/lower lows (LH/LL) bearish pattern instead of higher highs/higher lows (HH/HL) bullish pattern. This indicates the trend is continuing in the bearish direction; staying below EMA20 ($6.60) reinforces the short-term bearish bias. MTF analysis (1D/3D/1W) identifies 7 strong levels: mostly supports (total 4S/3R), increasing the risk of a potential breakdown. Supertrend is giving a bearish signal and resistance is positioned at $7.54. The market is awaiting CHoCH (Change of Character); trend reversal looks difficult without breaking the current LH/LL sequence.

Trend Analysis: Uptrend or Downtrend?

Uptrend Signals

Early signals for higher highs and higher lows are limited. Recently, the price tested the $6.2430 swing high and was rejected, reflecting a lack of bullish momentum. Although a positive histogram is visible on MACD (potential bullish divergence), RSI at 36.34 is near the oversold region but momentum has zeroed out. Critical for HH/HL structure: First, BOS above $6.2430 (61/100 score), then breaking EMA20 at $6.60 and forming a new HH are required. Currently, the $8.93 bullish target (26 score) is distant; only aggressive buying can trigger this structure. For short-term recovery, monitor the $6.31 24h high, but the overall trend remains bearish dominant.

Downtrend Risk

LH/LL pattern is clear: The latest swing high at $6.2430 failed to hold previous lows at $5.7530. This is the classic downtrend definition; price action cuts every rally with a lower high. $5.7530 swing low (75/100 score) is the main support; a break extends LH/LL and leads to the $2.5687 bearish target (22 score). Consistent with RSI decline, Supertrend bearish, and BTC downtrend pressuring altcoins. Risk increase: Additional LH formation on 3D/1W delays CHoCH.

Structure Break (BOS) Levels

BOS (Break of Structure) is the key to trend change. For bearish BOS: Close below $5.7530 swing low confirms LH/LL and targets new lower low. This level is a strong 1D support (75 score); breakout with volume brings aggressive downside. Bullish BOS: Impulse move above $6.2430 swing high invalidates LH and signals transition to HL sequence. Additional confirmation: $6.60 EMA20 and $7.54 Supertrend resistance. MTF shows 1W balance of 2S/2R, synchronized with $62k BTC support; BOS in either direction redefines the structure. Watch: Price pivots at $5.95; without BOS, range continues.

Swing Points and Their Importance

Recent Swing Highs

Latest swing high $6.2430 (61/100) is the peak of the recent rally and resistance. This level is part of the LH pattern; rejection shows seller dominance. Previous swing highs (around $6.31 24h) play a similar role. Importance: Breakout initiates bullish BOS and potential HH; failure deepens LH/LL. On the 1D chart, aligned with fib retracement 0.618 (61.8%), strong confluence.

Recent Swing Lows

$5.7530 swing low (75/100) is critical support and the latest LL. This point is the base of the downtrend; hold offers hope for HL, break leads to $2.56. LH/LL sequence with previous lows: Each bottom lower, bearish momentum. Importance: Defense line; volume hold sets up reversal, breakout continuation. MTF increases 3D/1W support confluence, linked to BTC $62.9k.

Bitcoin Correlation

BTC at $63,294 in downtrend (3.73% drop), Supertrend bearish; altcoins like ENS are highly correlated (0.85+). If BTC breaks $62,910 support, ENS tests $5.75; drop below $60k delays altseason. Conversely, BTC recovery above $64,632R triggers $6.24 BOS in ENS. Rising dominance (BTC bearish caution) crushes alts; ENS structure tied to BTC $49k deep support. Key: BTC key levels ($62.9S, $64.6R) direct ENS BOS – synchronized movement essential.

Structural Outlook and Expectations

Overall outlook bearish: LH/LL downtrend dominant, consolidation at $5.95 pivot. BOS levels decisive: $6.24+ bullish shift (CHoCH), $5.75- bearish extension. MTF balance (1D 1S/1R, 3D 1S/0R, 1W 2S/2R) risks downside; RSI/MACD divergences weak counter-signals. No news, focus on pure structure: Trend continuation likely, clean BOS required for reversal. Risk management: $5.75 stop, $6.24 target; high volatility, watch BTC. Educational note: HH/HL bullish bias, LH/LL bearish – current LH/LL gives short bias but watch BOS invalidation.

This analysis uses the market views and methodology of Chief Analyst Devrim Cacal.

Strategy Analyst: David Kim

Macro market analysis and portfolio management

This analysis is not investment advice. Do your own research.

Source: https://en.coinotag.com/analysis/ens-technical-analysis-24-february-2026-market-structure

Disclaimer: The articles reposted on this site are sourced from public platforms and are provided for informational purposes only. They do not necessarily reflect the views of MEXC. All rights remain with the original authors. If you believe any content infringes on third-party rights, please contact crypto.news@mexc.com for removal. MEXC makes no guarantees regarding the accuracy, completeness, or timeliness of the content and is not responsible for any actions taken based on the information provided. The content does not constitute financial, legal, or other professional advice, nor should it be considered a recommendation or endorsement by MEXC.
Tags:

You May Also Like

Vitalik Buterin to Ethereum Developers: Build It Like It Has to Last Without You

Vitalik Buterin to Ethereum Developers: Build It Like It Has to Last Without You

Key Takeaways Vitalik Buterin wants Ethereum apps built to survive without developers, corporate servers, or trusted third parties Two major […] The post Vitalik
Share
Coindoo2026/03/07 15:49
Non-Opioid Painkillers Have Struggled–Cannabis Drugs Might Be The Solution

Non-Opioid Painkillers Have Struggled–Cannabis Drugs Might Be The Solution

The post Non-Opioid Painkillers Have Struggled–Cannabis Drugs Might Be The Solution appeared on BitcoinEthereumNews.com. In this week’s edition of InnovationRx, we look at possible pain treatments from cannabis, risks of new vaccine restrictions, virtual clinical trials at the Mayo Clinic, GSK’s $30 billion U.S. manufacturing commitment, and more. To get it in your inbox, subscribe here. Despite their addictive nature, opioids continue to be a major treatment for pain due to a lack of effective alternatives. In an effort to boost new drugs, the FDA released new guidelines for non-opioid painkillers last week. But making these drugs hasn’t been easy. Vertex Pharmaceuticals received FDA approval for its non-opioid Journavx in January, then abandoned a next generation drug after a failed clinical trial earlier this summer. Acadia similarly abandoned a promising candidate after a failed trial in 2022. One possible basis for non-opioids might be cannabis. Earlier this year, researchers at Washington University at St. Louis and Stanford published a study showing that a cannabis-derived compound successfully eased pain in mice with minimal side effects. Munich-based pharmaceutical company Vertanical is perhaps the furthest along in this quest. It is developing a cannabinoid-based extract to treat chronic pain it hopes will soon become an approved medicine, first in the European Union and eventually in the United States. The drug, currently called Ver-01, packs enough low levels of cannabinoids (including THC) to relieve pain, but not so much that patients get high. Founder Clemens Fischer, a 50-year-old medical doctor and serial pharmaceutical and supplement entrepreneur, hopes it will become the first cannabis-based painkiller prescribed by physicians and covered by insurance. Fischer founded Vertanical, with his business partner Madlena Hohlefelder, in 2017, and has invested more than $250 million of his own money in it. With a cannabis cultivation site and drug manufacturing plant in Denmark, Vertanical has successfully passed phase III clinical trials in Germany and expects…
Share
BitcoinEthereumNews2025/09/18 05:26
Short-term profit-taking pushes Bitcoin back below key $70K level – What next?

Short-term profit-taking pushes Bitcoin back below key $70K level – What next?

The post Short-term profit-taking pushes Bitcoin back below key $70K level – What next? appeared on BitcoinEthereumNews.com. Bitcoin [BTC] rallied as high as $74
Share
BitcoinEthereumNews2026/03/07 16:09